Treatment of T3a bladder cancer with iridium implantation

Urology. 1993 Mar;41(3):217-20. doi: 10.1016/0090-4295(93)90559-s.

Abstract

A total of 7 patients with high grade, T3a (Stage B2) bladder cancer were treated with external radiation therapy and interstitial iridium implantation from May 1986 through March 1988. Follow-up has ranged from nineteen to sixty-one months with a median of forty months. One patient has required a cystectomy and is currently free of disease, and 1 patient has had recurrence of his cancer and metastatic carcinoma has developed; 5 are free of disease and have maintained their usual state of bladder function. Iridium implantation maintains bladder function and is effective therapy for selected individuals with localized, muscle-invading bladder cancer.

MeSH terms

  • Aged
  • Brachytherapy*
  • Carcinoma, Transitional Cell / epidemiology
  • Carcinoma, Transitional Cell / radiotherapy*
  • Female
  • Follow-Up Studies
  • Humans
  • Iridium Radioisotopes / therapeutic use*
  • Male
  • Neoplasm Recurrence, Local / epidemiology
  • Radiotherapy Dosage
  • Radiotherapy, High-Energy
  • Time Factors
  • Urinary Bladder Neoplasms / epidemiology
  • Urinary Bladder Neoplasms / radiotherapy*

Substances

  • Iridium Radioisotopes